FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to haemostasis and fibrinolysis system analysis methods. Coagulation properties of two citrated blood samples are analysed simultaneously by re-calcification with kaolin added. One blood sample is added with plasmin in amount 1.5 times extending coagulation time as compared to the reference thus calculating the coagulation prolongation percentage by formula: 
where twith plasm is coagulation time with plasmin, twithout plasm is coagulation time without plasmin. The coagulation prolongation percentage is compared to the reference results in hyperfibrinolysis prediction and diagnostics.
EFFECT: method provides improved quality of treatment ensured by higher diagnostic accuracy and possibility to predict thromboses and haemorrhages in surgical, therapeutic and neurologic patients.
3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF ESTIMATING CONDITION OF BLOOD COAGULATION SYSTEM IN PATIENTS IN CRITICAL CONDITION | 2012 |
|
RU2517116C2 |
| METHOD OF TREATMENT OF UPPER GASTROINTESTINAL BLEEDING | 2016 |
|
RU2657756C2 |
| METHOD OF HEMODIALYSIS AT PATIENTS WITH RISK OF BLEEDING | 2004 |
|
RU2343936C2 |
| METHOD OF PREVENTING BLEEDING CAUSED BY USE OF STREPTOKINASE IN EXPERIMENT | 2014 |
|
RU2552339C1 |
| DIAGNOSTIC TECHNIQUE FOR COAGULATION FAILURES IN PREGNANT WOMEN IN TRIMESTER 2-3 | 2014 |
|
RU2543653C1 |
| METHOD OF DIAGNOSIS OF HYPERFIBRINOLYSIS | 0 |
|
SU888943A1 |
| METHOD FOR DIFFERENTIAL DIAGNOSTICS OF HEMOSTASIS SYSTEM DISORDERS IN PATIENTS WITH ACUTE BLOOD LOSS | 2004 |
|
RU2263914C1 |
| METHOD OF PREVENTION OF BLEEDING CAUSED BY USE OF DABIGATRAN ETEXILATE IN EXPERIMENT | 2013 |
|
RU2552331C1 |
| METHOD FOR IDENTIFYING BLOOD HYPERCOAGULATION | 1991 |
|
RU2015515C1 |
| METHOD FOR DETECTING OF BLOOD PRODUCTS PARACOAGULATION | 2015 |
|
RU2605374C9 |
